Yamazaki, Kenji <br/><br/>
Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management.  [electronic resource] 

 -  Gut  Nov 2007 
 - 1557-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-3288 
<br/><br/><label>Standard No.: </label>10.1136/gut.2007.129858  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Caco-2 Cells<br/>Colonic Neoplasms--metabolism<br/>Drug Synergism<br/>Female<br/>Growth Inhibitors<br/>Humans<br/>Male<br/>PPAR gamma--metabolism<br/>Phosphorylation<br/>Retinoid X Receptor alpha--metabolism<br/>Thiazolidinediones--pharmacology<br/>Tretinoin--pharmacology